Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000099

President and CEO acquired 10,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2022-06-01 Option exercise +10,938 534,390 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Brunn Carsten President and CEO 2022-06-01 Option exercise · Restricted Stock Units −10,938 21,875 D: show line 2 in the form
Loading xslF345X03/wf-form4_165428903107199.xml…